FIELD: medicine; pharmaceuticals.
SUBSTANCE: group of inventions refers to pharmaceutical industry, namely to embodiments of a pharmacological composition for treating proctologic diseases. In the first embodiment, the declared composition consists of: 3.3–7.5 wt. % methyluracil, 0.13–0.3 wt. % nifedipine, 1.3–5 wt. % lidocaine, a pharmacologically acceptable carrier (rest). In the second embodiment, a composition is proposed, which consists of: 5 wt. % methyluracil, 0.2 wt. % nifedipine, 2-5 wt. % lidocaine, a pharmacologically acceptable carrier (rest). Compositions can be presented in the form of gel, ointment, cream, suppositories, suspended gel, lotion or emulsion.
EFFECT: group of inventions provides simplifying the manufacture of a composition for treating haemorrhoids and anal fissures, as well as intensifying the analgesic effect.
4 cl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING A PHARMACEUTICAL GEL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (VERSIONS) | 2020 |
|
RU2730483C1 |
PHARMACOLOGICAL COMPOSITION FOR TREATING PROCTOLOGIC DISEASES (VERSIONS) | 2013 |
|
RU2592366C2 |
COMPOSITION FOR TREATING ANAL CRACKS BASED ON FELODIPINE | 2019 |
|
RU2710742C1 |
COMPOSITION FOR TREATING ANAL FISSURES | 2013 |
|
RU2538079C1 |
COMPOSITION FOR TREATING ANAL FISSURES IN FORM OF CREAM | 2015 |
|
RU2595799C1 |
COMPOSITION FOR PREVENTING OR TREATING PROCTOLOGICAL DISEASES | 2022 |
|
RU2814279C2 |
GEL INCLUDING NIFEDIPINE AND LIDOCAINE HYDROCHLORIDE (VERSIONS), APPLICATION OF GEL INCLUDING NIFEDIPINE AND IDOCAINE HYDROCHLORIDE (VERSIONS), METHOD FOR PREPARATION OF GEL INCLUDING NIFEDIPINE AND IDOCAINE HYDROCHLORIDE, USING NANOTECHNOLOGY | 2015 |
|
RU2641570C2 |
TISOLUM-BASED PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ANAL FISSURES | 2012 |
|
RU2483721C1 |
THERAPEUTICAL COMPOSITION FOR LOCAL TREATMENT OF HEMORRHOIDS, ANUS FISSURES, AND INFLAMMATORY DISEASES OF MUCOUS MEMBRANE OF RECTUM | 2004 |
|
RU2277926C2 |
SUPPOSITORY SHOWING ANTIINFLAMMATORY EFFECT | 1995 |
|
RU2097022C1 |
Authors
Dates
2020-09-29—Published
2019-12-13—Filed